Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134) is a human monoclonal antibody targeting TNFRSF4 (TNF receptor superfamily member 4) and OX40. It can be used in cancer immunology research. MW :146.36 KD.

• Supplier: Selleck Chemicals
• Product #: A2683
• Sku #: A2683-1mg*5